Dr. Darius Francescatti, a breast surgeon with Rush University Medical Center, discusses the latest technological advances designed to enhance the effectiveness of lumpectomy procedures, including the use of 3D tomography (Kubtec’s Mozart System) in the operating room, and why the 20 percent average re-excision rate for the U.S. is too high.
Darius Francescatti, MD FACS, is a board-certified general surgeon at Rush University Medical Center with a practice solely limited to breast oncology. Dr. Francescatti, who also holds a JD, has over 48 years of experience in the field of medicine. He is an Assistant Professor of Surgery at Rush University Medical Center in Chicago.
Dr. Francescatti received his medical degree from Loyola University Chicago Stritch School of Medicine and completed his residency at Loyola University Medical Center. He is a fellow of the American College of Surgeons (ACS) and a member of the American Society of Breast Surgeons (ASBrS). He has had extensive experience in postgraduate education for both the ACS and ASBrS on numerous topics at the forefront of breast surgical oncology; breast ultrasound, the use of mammography for both diagnosis and intraoperative specimen analysis, 3D breast ultrasound and color doppler in the analysis of breast abnormalities.
Dr. Francescatti has delivered educational presentations on various surgical techniques and technologies that facilitate the treatment of breast cancer both at home and at numerous international medical conferences in Europe and Asia including presentations in Rome, Romania, Taiwan and Beijing and in the United States at the Miami Breast Conference and multiple clinical congress sites for the American College of Surgeons. Presentation content has and is focused on specific topics on the diagnosis and/or treatment of breast cancer, including breast cancer image analysis, intra-operative radiotherapy for breast cancer, office-based breast ductoscopy, ductal lavage for high-risk assessment in women, accelerated partial breast radiation and nipple discharge as an aid to diagnosis.
Dr. Francescatti is a co-author with Melvin J. Silverstein of a book entitled “Breast Cancer: A New Era in Management”. He is the author or co-author of several papers on breast cancer diagnosis and treatment in clinical journals including the World Journal of Surgical Oncology, Annals of Surgical Oncology, The Breast Journal and the American Journal of Surgery. As examples, clinical articles have addressed breast-image guided surgery of small breast cancers, laser therapy of breast cancer, cryoablation of breast fibroadenoma and fine-needle aspiration of suspicious breast masses as well as other topics.
Dr. Francescatti’s professional interests are directed at advancing technologies that improve surgical outcomes for breast cancer patients. He was an early adopter of breast ultrasound, ductal lavage and ductoscopy, cryo and laser ablation of breast tumors, accelerated partial breast irradiation and intraoperative radiotherapy, the use of genomic molecular subtyping of breast cancer and, most recently, breast thermography as a risk assessment tool. He currently serves as a consultant for Kubtec Medical Imaging which has introduced the Mozart 3-D tomographic intraoperative specimen imaging system.
Dr. Francescatti has worked in the health care industry in a number of capacities. He has functioned as an ombudsman on regulatory issues, acted as the interface between the clinical and commercial world, developed intellectual property concepts, co-authored patents, developed educational material for both employees and clinicians, and provided insight into and developed marketing material. He has authored a number of white papers on various topics germane to health care diagnosis and therapy.
In addition to his interest in breast surgical oncology and technologies that advance the identification of and surgical treatment of breast cancer, Dr. Francescatti has studied the French and Italian languages and has an avid interest in both history and geology and remains an avid reader of current worldwide events.